Advanced post-mastectomy breast reconstruction improves women's psychosocial and sexual well-being

October 24, 2011

After a mastectomy, women who undergo breast reconstruction with tissue from their own abdomen experience significant gains in psychological, social, and sexual wellbeing as soon as three weeks after surgery. That is one of the conclusions of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results provide new information to breast cancer survivors who are contemplating these types of breast reconstruction procedures.

The goal of breast reconstruction after a mastectomy is to restore the appearance of the breast and to improve women's after . But how successful is it? Recent studies on the health and wellbeing of women who undergo breast reconstruction have generated mixed findings.

To provide a clearer picture of women's mental and physical health following two advanced forms of breast reconstruction, Toni Zhong, MD, MHS, of the University Health Network Breast Restoration Program at the University of Toronto in collaboration with her colleagues at Memorial Sloan Kettering Cancer Center in New York City surveyed 51 women undergoing free MS-TRAM or DIEP flap reconstruction between June 2009 and November 2010. During these procedures, which are gaining popularity in North America and Europe, surgeons take tissue from the patient's abdomen and use it to reconstruct the breast. The women in the study completed questionnaires prior to surgery and following surgery at three weeks and three months.

Women who underwent the breast reconstruction procedures reported significant improvements in psychological, social, and sexual wellbeing just three weeks after surgery. Unfortunately, however, they continued to experienced decreased physical wellbeing at the abdominal location where tissue was removed at three months following surgery.

The results may be helpful to who are considering breast reconstruction. "In the current healthcare environment where patients and providers increasingly seek evidence-based data to guide clinical decisions, discussing satisfaction outcomes with patients will help them make educated decisions about ," said Dr. Zhong. "Our study can serve as an important source of evidence to guide the decision-making process for both surgeons and patients," she added.

Explore further: Most breast cancer patients do not have breast reconstruction surgery

Related Stories

Most breast cancer patients do not have breast reconstruction surgery

October 20, 2011
Only seven per cent of female breast cancer patients opt for breast reconstruction surgery.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.